Stock listing
NASDAQ:ALGS Aligos Therapeutics, Inc. Stock
Home listing (NASDAQ) of Aligos Therapeutics, Inc.
Follow Aligos Therapeutics, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:ALGS
$1.22 USD -0.08 (-6.2%)
Close on Nov 20, 2026
- Day range
- $1.18 – $1.34 USDNov 20, 2026
- Volume
- 105,409 sharesNov 20, 2026
- Market cap
- $6.64M USDAt the close on Nov 20, 2026 · price × 5.44M shares outstanding
- 52-week range
- $1.18 – $13.69 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $254,362 USDMedian day 42,100 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:ALGS · Home | $1.22 USD | -0.08 (-6.2%) | 105,409 | $1.26 | $1.336 | $1.175 | $1.30 | Close on Nov 20, 2026 |
| Frankfurt:5WK0 | €1.138 EUR | -0.044 (-3.7%) | 190 | €1.106 | €1.138 | €1.106 | €1.182 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:ALGS · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $1.22 | -0.08 | -6.2% | $1.26 | $1.336 | $1.175 | 105,409 | |
| $1.30 | -0.06 | -4.4% | $1.39 | $1.58 | $1.25 | 109,147 | |
| $1.36 | -0.30 | -18.1% | $1.63 | $1.63 | $1.36 | 57,117 | |
| $1.66 | -0.44 | -21.0% | $2.00 | $2.00 | $1.58 | 139,603 | |
| $2.10 | +0.12 | +6.1% | $2.09 | $2.245 | $1.98 | 57,515 | |
| $1.98 | -0.18 | -8.3% | $2.21 | $2.316 | $1.92 | 120,576 | |
| $2.16 | -0.41 | -16.0% | $2.79 | $2.81 | $2.02 | 283,400 | |
| $2.57 | -1.38 | -34.9% | $3.99 | $3.99 | $2.56 | 194,200 | |
| $3.95 | -0.12 | -2.9% | $4.25 | $4.65 | $3.95 | 141,300 | |
| $4.07 | -0.44 | -9.8% | $4.44 | $4.855 | $4.00 | 101,700 | |
| $4.51 | -0.51 | -10.2% | $5.004 | $5.004 | $4.505 | 40,200 | |
| $5.02 | +0.27 | +5.7% | $4.89 | $5.14 | $4.721 | 27,800 | |
| $4.75 | +0.15 | +3.3% | $4.65 | $4.95 | $4.65 | 13,900 | |
| $4.60 | -0.20 | -4.2% | $4.81 | $4.99 | $4.60 | 23,000 | |
| $4.80 | -0.23 | -4.6% | $4.99 | $5.05 | $4.75 | 23,800 | |
| $5.03 | -0.14 | -2.7% | $5.02 | $5.375 | $5.02 | 47,200 | |
| $5.17 | +0.43 | +9.1% | $4.66 | $5.26 | $4.66 | 23,500 | |
| $4.74 | +0.09 | +1.9% | $4.67 | $4.81 | $4.63 | 9,500 | |
| $4.65 | -0.13 | -2.7% | $4.98 | $4.98 | $4.55 | 33,000 | |
| $4.78 | -0.04 | -0.8% | $4.76 | $4.92 | $4.65 | 4,800 | |
| $4.82 | -0.14 | -2.8% | $5.005 | $5.005 | $4.78 | 15,300 | |
| $4.96 | -0.07 | -1.4% | $4.88 | $5.235 | $4.88 | 13,100 | |
| $5.03 | +0.19 | +3.9% | $4.74 | $5.241 | $4.74 | 42,800 | |
| $4.84 | -0.02 | -0.4% | $4.95 | $5.08 | $4.61 | 82,000 | |
| $4.86 | -0.53 | -9.8% | $5.32 | $5.50 | $4.86 | 67,600 | |
| $5.39 | +0.16 | +3.1% | $5.40 | $5.409 | $5.186 | 25,500 | |
| $5.23 | -0.28 | -5.1% | $5.50 | $5.60 | $5.21 | 60,600 | |
| $5.51 | -0.02 | -0.4% | $5.465 | $5.60 | $5.20 | 34,000 | |
| $5.53 | +0.19 | +3.6% | $5.50 | $5.64 | $5.30 | 57,300 | |
| $5.34 | +0.03 | +0.6% | $5.27 | $5.442 | $5.27 | 8,900 | |
| $5.31 | -0.01 | -0.2% | $5.25 | $5.53 | $5.08 | 37,400 | |
| $5.32 | -0.06 | -1.1% | $5.33 | $5.525 | $5.23 | 19,400 | |
| $5.38 | -0.02 | -0.4% | $5.46 | $5.53 | $5.31 | 12,800 | |
| $5.40 | -0.14 | -2.5% | $5.57 | $5.65 | $5.35 | 48,600 | |
| $5.54 | +0.04 | +0.7% | $5.58 | $5.72 | $5.37 | 29,000 | |
| $5.50 | -0.13 | -2.3% | $5.69 | $5.74 | $5.367 | 28,300 | |
| $5.63 | +0.01 | +0.2% | $5.65 | $5.80 | $5.54 | 35,300 | |
| $5.62 | +0.08 | +1.4% | $5.53 | $5.68 | $5.40 | 11,500 | |
| $5.54 | +0.03 | +0.5% | $5.38 | $5.54 | $5.18 | 79,500 | |
| $5.51 | -0.04 | -0.7% | $5.70 | $5.765 | $5.47 | 45,000 | |
| $5.55 | -0.01 | -0.2% | $5.55 | $5.695 | $5.27 | 59,600 | |
| $5.56 | -0.12 | -2.1% | $5.72 | $5.936 | $5.45 | 35,100 | |
| $5.68 | +0.19 | +3.5% | $5.57 | $6.30 | $5.222 | 75,700 | |
| $5.49 | +0.25 | +4.8% | $5.31 | $5.88 | $5.21 | 125,000 | |
| $5.24 | +0.07 | +1.4% | $5.15 | $5.25 | $5.015 | 21,300 | |
| $5.17 | +0.12 | +2.4% | $5.10 | $5.29 | $5.10 | 21,700 | |
| $5.05 | +0.06 | +1.2% | $5.01 | $5.13 | $4.93 | 41,700 | |
| $4.99 | -0.05 | -1.0% | $5.04 | $5.445 | $4.82 | 34,100 | |
| $5.04 | -0.18 | -3.4% | $5.17 | $5.27 | $5.02 | 28,000 | |
| $5.22 | -0.11 | -2.1% | $5.39 | $5.502 | $5.14 | 37,000 | |
| $5.33 | -0.17 | -3.1% | $5.38 | $5.48 | $5.21 | 46,100 | |
| $5.50 | -0.26 | -4.5% | $5.79 | $6.02 | $5.41 | 33,000 | |
| $5.76 | -0.45 | -7.2% | $6.21 | $6.34 | $5.62 | 63,600 | |
| $6.21 | -0.01 | -0.2% | $6.16 | $6.21 | $6.02 | 20,300 | |
| $6.22 | +0.01 | +0.2% | $6.22 | $6.48 | $6.07 | 42,100 | |
| $6.21 | +0.12 | +2.0% | $6.15 | $6.64 | $6.01 | 55,200 | |
| $6.09 | +0.23 | +3.9% | $5.76 | $6.22 | $5.61 | 101,600 | |
| $5.86 | -1.05 | -15.2% | $6.83 | $6.83 | $5.86 | 98,700 | |
| $6.91 | -0.16 | -2.3% | $7.025 | $7.10 | $6.64 | 39,100 | |
| $7.07 | -0.44 | -5.9% | $7.44 | $7.495 | $6.82 | 80,300 | |
| $7.51 | +0.04 | +0.5% | $7.37 | $7.72 | $7.04 | 68,900 | |
| $7.47 | +0.54 | +7.8% | $6.93 | $7.538 | $6.71 | 93,400 | |
| $6.93 | +0.26 | +3.9% | $6.61 | $7.00 | $6.40 | 33,200 | |
| $6.67 | +0.23 | +3.6% | $6.48 | $6.799 | $6.40 | 52,300 | |
| $6.44 | -0.45 | -6.5% | $6.77 | $7.006 | $6.35 | 62,500 |
Splits
1 split · NASDAQ:ALGS · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-25 | Consolidation |
- Ticker
- NASDAQ:ALGS
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Nov 6, 2026
Aligos Therapeutics Reports Recent Business Progress and Third Quarter 2026 Financial Results
Latest news
Aligos Therapeutics Reports Recent Business Progress and Third Quarter 2026 Financial Results
Nov 6, 2026
Closed $4.07 (-9.8%) on Nov 6, 2026
Aligos Therapeutics Presents Positive Data at The Liver Meeting® 2026
Nov 5, 2026
Closed $4.07 (-9.8%) on Nov 6, 2026
Aligos Therapeutics Announces Five Abstracts Accepted for Presentation at The Liver Meeting® 2026
Oct 5, 2026
Closed $5.38 (-0.4%) on Oct 6, 2026
Aligos Therapeutics to Present at the Cantor Global Healthcare Conference
Sep 2, 2026
Closed $6.21 (+2.0%) on Sep 2, 2026
Aligos Therapeutics Announces First Participant Dosed in the Phase 1 Study of its Potentially Best-in-Class Antisense Oligonucleotide ALG-170675 by its Partner Amoytop in China
Aug 12, 2026
Closed $6.77 (-3.3%) on Aug 13, 2026
Aligos Therapeutics to Announce 2nd Quarter 2026 Financial Results on August 6, 2026
Jul 30, 2026
Closed $4.32 (+1.6%) on Jul 30, 2026
Aligos Therapeutics Announces the Completion of Enrollment in the Phase 2 B-SUPREME Study of Pevifoscorvir Sodium Under Development for the Treatment of Chronic HBV Infection
Jul 13, 2026
Closed $6.36 (-3.9%) on Jul 13, 2026
Aligos Therapeutics Receives Upfront Payment of $25M USD from the Exclusive License Deal of Pevifoscorvir Sodium in Greater China for Chronic Hepatitis B Virus Infection
Jul 6, 2026
Closed $6.09 (+4.1%) on Jul 7, 2026
Aligos Therapeutics Presents Positive Data at the EASL Congress 2026
May 27, 2026
Closed $5.60 (-2.4%) on May 27, 2026
Aligos Therapeutics Announces Ten Abstracts Accepted for Presentation at the EASL Congress 2026
May 13, 2026
Closed $6.67 (+3.1%) on May 13, 2026
Financings
Private placement of common stock, pre-funded warrants and accompanying warrants
Feb 12, 2025
Announced: about US$105M · US$26.0825 a share · Warrants at US$26.02 · Jefferies +2
Dealers: Jefferies, Piper Sandler, H.C. Wainwright & Co.
Use of proceeds: Advance ALG-000184 into a Phase 2 study in chronic hepatitis B and general corporate purposes
Decks
APASL 2025
Conference · 19 slides · March 2025
Technical Presentation (November 2024)
Technical · 19 slides · Nov 1, 2024
Investor Presentation (October 2024)
Investor deck · 43 slides · October 2024
Investor Presentation (August 2024)
Investor deck · 41 slides · August 2024
Aligos Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 22 in the last 12 months · 135 in all · newest Nov 6, 2026 · oldest 2020
- Decks
- 34 decks · latest March 2025
Where Aligos Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:ALGS · Home listing · This page | NASDAQ | United States | USD |
| BOATS:ALGS | BOATS | United States | USD |
| gettex:5WK0 | gettex | Germany | EUR |
| LS Exchange:A40LQ4 | LS Exchange | Germany | EUR |
| Lang & Schwarz:A40LQ4 | Lang & Schwarz | Germany | EUR |
| Tradegate:5WK0 | Tradegate | Germany | EUR |
| Dusseldorf:5WK0 | Dusseldorf | Germany | EUR |
| Frankfurt:5WK0 | Frankfurt | Germany | EUR |
| Munich:5WK0 | Munich | Germany | EUR |
| Stuttgart:5WK0 | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Aligos Therapeutics, Inc.